<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>2979</number>
    <updateDate>2023-01-11T13:43:52Z</updateDate>
    <updateDateIncludingText>2023-01-11T13:43:52Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <type>S</type>
    <introducedDate>2019-12-04</introducedDate>
    <congress>116</congress>
    <committees>
      <item>
        <systemCode>sscm00</systemCode>
        <name>Commerce, Science, and Transportation Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2020-12-15T23:55:23Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2019-12-11T15:00:48Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2019-12-04T22:51:40Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>S. Rept. 116-328</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>Impaired Driving Study Act of 2019</title>
        <congress>116</congress>
        <number>3888</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-07-24</actionDate>
          <text>Referred to the Subcommittee on Consumer Protection and Commerce.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2020-12-15</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 634.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2020-12-15</actionDate>
        <committees>
          <item>
            <systemCode>sscm00</systemCode>
            <name>Commerce, Science, and Transportation Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with an amendment in the nature of a substitute. With written report No. 116-328.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2020-12-15</actionDate>
        <text>Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with an amendment in the nature of a substitute. With written report No. 116-328.</text>
        <type>Committee</type>
        <actionCode>14000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>sscm00</systemCode>
            <name>Commerce, Science, and Transportation Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-12-11</actionDate>
        <committees>
          <item>
            <systemCode>sscm00</systemCode>
            <name>Commerce, Science, and Transportation Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-12-04</actionDate>
        <committees>
          <item>
            <systemCode>sscm00</systemCode>
            <name>Commerce, Science, and Transportation Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Commerce, Science, and Transportation.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2019-12-04</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>W000437</bioguideId>
        <fullName>Sen. Wicker, Roger F. [R-MS]</fullName>
        <firstName>Roger</firstName>
        <lastName>Wicker</lastName>
        <party>R</party>
        <state>MS</state>
        <middleName>F.</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2020-02-14T16:00:00Z</pubDate>
        <title>S. 2979, Preventing Opioid and Drug Impairment in Transportation Act</title>
        <url>https://www.cbo.gov/publication/56141</url>
        <description>As ordered reported by the Senate Committee on Commerce, Science, and Transportation on December 11, 2019</description>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Transportation and Public Works</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
        </item>
        <item>
          <name>Canada</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Department of Transportation</name>
        </item>
        <item>
          <name>Drug trafficking and controlled substances</name>
        </item>
        <item>
          <name>Drug, alcohol, tobacco use</name>
        </item>
        <item>
          <name>Government information and archives</name>
        </item>
        <item>
          <name>Government studies and investigations</name>
        </item>
        <item>
          <name>Latin America</name>
        </item>
        <item>
          <name>Licensing and registrations</name>
        </item>
        <item>
          <name>Mexico</name>
        </item>
        <item>
          <name>Pipelines</name>
        </item>
        <item>
          <name>Railroads</name>
        </item>
        <item>
          <name>Roads and highways</name>
        </item>
        <item>
          <name>Transportation employees</name>
        </item>
        <item>
          <name>Transportation safety and security</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Transportation and Public Works</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2019-12-04</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2021-03-31T18:43:16Z</updateDate>
        <text><![CDATA[ <p><b>Preventing Opioid and Drug Impairment in Transportation Act</b></p> <p>This bill addresses drug and alcohol testing for transportation-related activities.</p> <p>Specifically, the bill requires</p> <ul> <li>the National Railroad Passenger Corporation (Amtrak) to report on methods it uses to ensure supervisors of employees in safety-sensitive positions receive the required training on how to detect drug and alcohol use;</li> <li>the Department of Transportation (DOT) to determine whether to mandate that Amtrak locomotive engineers and conductors report arrests due to drug or alcohol offenses;</li> <li>DOT to report on the ability of pipeline companies that operate from Canada or Mexico into the United States to conduct the same drug and alcohol tests of safety-sensitive personnel that are required in the United States;</li> <li>DOT to amend its auditing program to improve the efficiency of certain drug and alcohol regulations related to testing contractors working in multiple states;</li> <li>the National Highway Traffic Safety Administration to study the ways it can reduce and better detect impaired driving, including marijuana- and opioid-impaired driving;</li> <li>DOT to conduct a study regarding the accuracy of on-site oral fluid screening for tetrahydrocannabinol and opiate presence in order to reduce the potential impact on traffic safety due to drug and polysubstance-impaired drivers;</li> <li> the Government Accountability Office to review DOT's process for setting guidelines and drug testing requirements for transportation employees; and</li> <li>reports on whether to add fentanyl to the drug testing panel and the status of the guidelines for hair testing of transportation employees.</li> </ul>]]></text>
      </summary>
      <summary>
        <versionCode>25</versionCode>
        <actionDate>2020-12-15</actionDate>
        <actionDesc>Reported to Senate</actionDesc>
        <updateDate>2021-05-04T19:08:36Z</updateDate>
        <text><![CDATA[ <p><b>Preventing Opioid and Drug Impairment in Transportation Act</b></p> <p>This bill addresses drug and alcohol testing for transportation-related activities.</p> <p>Specifically, the bill requires</p> <ul> <li>the National Railroad Passenger Corporation (Amtrak) to report on methods it uses to ensure supervisors of employees in safety-sensitive positions receive the required training on how to detect drug and alcohol use and training on the rights and responsibilities of employees throughout the drug and alcohol testing process;</li> <li>the Department of Transportation (DOT) to determine whether to mandate that Amtrak locomotive engineers and conductors report arrests due to drug or alcohol offenses;</li> <li>DOT to report on the ability of pipeline companies that operate from Canada or Mexico into the United States to conduct the same drug and alcohol tests of safety-sensitive personnel that are required in the United States;</li> <li>DOT to amend its auditing program to improve the efficiency of certain drug and alcohol regulations related to testing contractors working in multiple states;</li> <li>the National Highway Traffic Safety Administration to study the ways it can reduce and better detect impaired driving, including marijuana- and opioid-impaired driving;</li> <li>DOT to conduct a study on the accuracy of on-site oral fluid screening for tetrahydrocannabinol and opiate presence in order to reduce the potential impact on traffic safety due to drug and polysubstance-impaired drivers;</li> <li> the Government Accountability Office to review DOT's process for setting guidelines and drug testing requirements for transportation employees; </li> <li>reports on whether to add fentanyl to the drug testing panel and the status of the guidelines for hair testing of transportation employees;</li> <li>DOT to report on the current status and operational potential of the Driver Alcohol Detection System for Safety Program's alcohol detection technology; and</li> <li>DOT to identify the barriers states face in submitting toxicology results of fatally injured drivers, provide recommendations to address such barriers, and establish minimum guidelines for toxicological investigations.</li> </ul>]]></text>
      </summary>
    </summaries>
    <title>Preventing Opioid and Drug Impairment in Transportation Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Preventing Opioid and Drug Impairment in Transportation Act</title>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Preventing Opioid and Drug Impairment in Transportation Act</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to Senate</titleType>
        <title>Preventing Opioid and Drug Impairment in Transportation Act</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Reported to Senate</billTextVersionName>
        <billTextVersionCode>RS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to improve drug testing for transportation-related activities.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Reported to Senate</type>
        <date>2020-12-15T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116s2979rs/xml/BILLS-116s2979rs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in Senate</type>
        <date>2019-12-04T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116s2979is/xml/BILLS-116s2979is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2020-12-15</actionDate>
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 634.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
